Paul A. Friedman
2016 - Synta Pharmaceuticals
In 2016, Paul A. Friedman earned a total compensation of $4M as Chief Executive Officer at Synta Pharmaceuticals.
Compensation breakdown
| Bonus | $84,000 |
|---|---|
| Option Awards | $2,278,545 |
| Salary | $175,898 |
| Stock Awards | $1,447,060 |
| Other | $465 |
| Total | $3,985,968 |
Friedman received $2.3M in option awards, accounting for 57% of the total pay in 2016.
Friedman also received $84K in bonus, $175.9K in salary, $1.4M in stock awards and $465 in other compensation.
Rankings
In 2016, Paul A. Friedman's compensation ranked 2,244th out of 14,075 executives tracked by ExecPay. In other words, Friedman earned more than 84.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,244 out of 14,075 | 84th |
Division Manufacturing | 780 out of 5,486 | 86th |
Major group Chemicals And Allied Products | 227 out of 1,900 | 88th |
Industry group Drugs | 165 out of 1,543 | 89th |
Industry Pharmaceutical Preparations | 131 out of 1,173 | 89th |
Source: SEC filing on April 27, 2018.
Friedman's colleagues
We found two more compensation records of executives who worked with Paul A. Friedman at Synta Pharmaceuticals in 2016.